Marion Mass, a pediatrician and co-founder of Free2Care, has raised concerns about the misuse of the 340B Drug Pricing Program by large healthcare corporations. Read More »
David Balto, a former policy director at the Federal Trade Commission (FTC), has raised concerns about the 340B drug discount program, alleging that it is being manipulated by corporate hospital systems and large pharmacies to the detriment of... Read More »
Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »
The National Consumers League (NCL) has announced the results of a national Morning Consult poll, which reveals significant public support for comprehensive reforms to the 340B Drug Pricing Program. Read More »
Gerard Acloque, a doctor at The Florida Concierge Medicine & Wellness, expressed concerns over Eli Lilly's legal actions against compounding pharmacies and telehealth companies producing compounded Tirzepatide. Read More »
Craig Brockie, founder of Ultimate Health Solutions, has expressed concerns about the priorities of large pharmaceutical companies. Read More »
Shaun Noorian, CEO of Empower Pharmacy, said that the U.S. pharmaceutical industry distorts global drug markets through excessive lobbying and anti-competitive practices. Read More »
The National Library of Medicine has announced that compounded medications offer therapeutic alternatives for patients with unique medical needs that cannot be met by U.S. Food and Drug Administration (FDA)-approved drugs. Read More »
Centene Corporation (NYSE: CNC) announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. Read More »
The U.S. Food and Drug Administration (FDA) recently issued the first emergency use authorization (EUA) allowing the Pfizer-BioNTech COVID-19 vaccine to be distributed in the U.S., according to a release by the FDA. Read More »
The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »
The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »
Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »
The Food and Drug Administration announced Fresh Express is recalling limited numbers of its Caesar Supreme kit over concerns of E. coli STEC 026 contamination, according to a press release. Read More »
U.S. Surgeon General Jerome Adams recently released a Call to Action to Control Hypertension, noting the important role of pharmacists beyond simply dispensing prescriptions. Read More »
The American Pharmacists Association (APhA) has partnered with Washington State University College of Pharmacy and Pharmaceutical Sciences to launch a program to prepare pharmacists to meet education requirements to administer vaccinations to children ages three to 18, according to a news release on the APhA's website. Read More »
Mylan N.V. (NASDAQ: MYL) announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials and Tranexamic Acid Injection, USP 1000 mg/10 mL, packaged in cartons of 10 single-dose 10 mL vials. Read More »
In a recent response to President Donald Trump's executive order regarding essential medicines, the Association for Accessible Medicines highlighted the importance of generic and biosimilar medicines for ensuring the health and well-being of U.S. residents. Read More »
The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »
To control the opioid crisis, states are developing programs within the health care system to fight opioid use disorder (OUD) by increasing both the access to and quality of available treatment for those afflicted. Read More »
Alerts Sign-up
